Publisher Correction: Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.
Rodón J, Damian S, Furqan M, García-Donas J, Imai H, Italiano A, Spanggaard I, Ueno M, Yokota T, Veronese ML, Oliveira N, Li X, Gilmartin A, Schaffer M, Goyal L.
Rodón J, et al. Among authors: li x.
Nat Med. 2024 May 24. doi: 10.1038/s41591-024-03072-w. Online ahead of print.
Nat Med. 2024.
PMID: 38789647
No abstract available.